STOCK TITAN

Pluri (PLUR) adds near-zero strike warrants in cash raise

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Pluri Inc. (PLUR) entered into a Purchase Agreement with an institutional investor for a registered direct offering of 1,200,000 common shares at $1.50 per share and Pre-Funded Warrants to purchase up to 1,028,940 common shares at an exercise price of $0.00001 per share. The Pre-Funded Warrants were sold at $1.49999 each and are exercisable immediately until fully exercised. In a concurrent private placement, Pluri issued Common Warrants to purchase 2,228,940 common shares at an exercise price of $1.65, first exercisable six months after issuance and lasting five years. Net proceeds are expected to be about $2,984,808, to be used for corporate development, general purposes and working capital. A.G.P./Alliance Global Partners acted as sole placement agent, receiving a 6.50% cash fee on gross proceeds plus up to $50,000 in expenses. The company and its directors/officers agreed to 45‑day lock-ups and a six‑month prohibition on variable rate transactions, subject to limited exceptions including an ATM with A.G.P. after 30 days.

Positive

  • None.

Negative

  • None.
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Common shares sold 1,200,000 shares Registered direct offering common shares
Pre-Funded Warrants underlying shares 1,028,940 shares Common shares issuable upon exercise of Pre-Funded Warrants
Common Warrants underlying shares 2,228,940 shares Common shares issuable upon exercise of Common Warrants
Offering price per common share $1.50 per share Price in registered direct offering
Pre-Funded Warrant price $1.49999 per Pre-Funded Warrant Equals share price less $0.00001 exercise price
Pre-Funded Warrant exercise price $0.00001 per share Initial exercise price, subject to adjustments
Common Warrant exercise price $1.65 per share Exercise price for Common Warrants
Expected net proceeds $2,984,808 Net proceeds from the Offering after fees and expenses
registered direct offering financial
"agreed to issue and sell in a registered direct offering"
A registered direct offering is a way for a company to sell new shares of its stock directly to select investors with regulatory approval. This method allows the company to raise funds quickly and efficiently without needing a public auction, similar to offering exclusive access to a limited number of buyers. For investors, it often provides an opportunity to purchase shares at a favorable price, while giving the company immediate access to capital.
Pre-Funded Warrants financial
"pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
Common Warrants financial
"common purchase warrants (the “Common Warrants”) to purchase one"
A common warrant is a tradable instrument that gives its holder the right to buy a company’s common shares at a fixed price within a set time period, similar to a coupon that can be redeemed later to purchase stock. Investors care because exercising warrants can boost potential gains if the stock rises, but it can also dilute existing shareholders by increasing the number of shares outstanding, which can lower per-share value.
Variable Rate Transaction financial
"involving a Variable Rate Transaction (as defined in the Purchase Agreement)"
at the market offering financial
"may enter into and/or issue Common Shares in an “at the market offering”"
An at-the-market offering is a way a company raises cash by selling newly issued shares directly into the open market at prevailing prices, rather than all at once in a single deal. Think of it like turning a faucet on to drip shares into trading at current prices when needed; it gives the company flexibility to raise funds over time but can dilute existing shareholders and potentially affect the stock price, which investors should monitor.
Regulation D regulatory
"in reliance upon the exemption from registration pursuant to Section 4(a)(2) under the Securities Act and Regulation D"
Regulation D is a set of rules that govern how companies can raise money from investors without going through the full process required for public stock offerings. It provides simplified options for private placements, making it easier for companies to seek investments from a smaller group of investors. For investors, it offers opportunities to invest in private companies, often with fewer restrictions, but also with different levels of risk and disclosure.

FAQ

What securities is Pluri Inc. (PLUR) issuing in this 8-K transaction?

Pluri Inc. is issuing 1,200,000 common shares, Pre-Funded Warrants to purchase up to 1,028,940 common shares, and Common Warrants to purchase 2,228,940 common shares. The common shares and Pre-Funded Warrants are part of a registered direct offering, and the Common Warrants are issued in a concurrent private placement.

What is the expected net proceeds amount from Pluri (PLUR)'s offering?

Pluri expects net proceeds of approximately $2,984,808 from the combined registered direct offering and concurrent private placement, after deducting placement agent fees and other estimated offering expenses. The company plans to use these proceeds for corporate development, general corporate purposes and working capital.

What are the pricing terms for Pluri (PLUR)'s shares and Pre-Funded Warrants?

Each Pluri common share is priced at $1.50. Each Pre-Funded Warrant is priced at $1.49999, equal to the share price minus the $0.00001 exercise price per warrant share. The Pre-Funded Warrants are exercisable immediately until all are exercised in full.

What are the key terms of Pluri (PLUR)'s Common Warrants?

Pluri’s Common Warrants allow purchase of 2,228,940 common shares at an exercise price of $1.65 per share. They become initially exercisable six months after issuance and remain exercisable for a period of five years from the initial exercise date.

What compensation does A.G.P./Alliance Global Partners receive in Pluri (PLUR)'s offering?

A.G.P./Alliance Global Partners, as sole placement agent, is entitled to a cash fee of 6.50% of the gross proceeds Pluri receives at closing, plus reimbursement of certain accountable expenses up to $50,000. These costs are deducted in arriving at the net proceeds figure.

What lock-up and issuance restrictions did Pluri (PLUR) agree to in this deal?

Pluri agreed that for 45 days after closing it will not issue most new equity or file registration statements, subject to limited exceptions. For six months, it is prohibited from variable rate transactions, but may undertake an at the market offering with A.G.P. after 30 days.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001158780 0001158780 2026-08-26 2026-08-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): August 28, 2026 (August 26, 2026)

 

PLURI INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Nevada   001-31392   98-0351734
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

MATAM Advanced Technology Park    
Building No. 5    
Haifa, Israel   3508409
(Address of Principal Executive Offices)   (Zip Code)

 

011 972 74 710 7171

(Registrant’s telephone number, including area code)

 

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Shares, par value $0.00001 per share   PLUR   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On August 26, 2026, Pluri Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with a certain institutional investor (the “Purchaser”) pursuant to which the Company agreed to issue and sell in a registered direct offering (the “Registered Direct Offering”) registered under the Securities Act of 1933, as amended (the “Securities Act”), an aggregate of (i) 1,200,000 (the “Shares”) of the Company’s common shares (“Common Shares”) and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 1,028,940 Common Shares (such shares issuable upon exercise of the Pre-Funded Warrants, the “Pre-Funded Warrant Shares”, and together with the Shares and the Pre-Funded Warrants, the “Securities”). Each Share was offered and sold at an offering price of $1.50 before deducting placement agent fees and other offering expenses, and each Pre-Funded Warrant was offered and sold at an offering price of $1.49999 which is equal to the offering price per share less the $0.00001 exercise price of each Pre-Funded Warrant, before deducting placement agent fees and other offering expenses.

 

Each Pre-Funded Warrant has an initial exercise price per share of $0.00001, subject to certain adjustments. The Pre-Funded Warrants are exercisable immediately and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full.

 

Additionally, pursuant to the Purchase Agreement, the Company agreed to issue to the Purchaser, in a concurrent private placement (the “Concurrent Private Placement” and, together with the Registered Direct Offering, the “Offering”), common purchase warrants (the “Common Warrants”) to purchase one Common Share for each Share or Pre-Funded Warrant purchased in the Registered Direct Offering for an aggregate of 2,228,940 Common Shares. The Common Warrants will be initially exercisable six (6) months following their issuance and will be exercisable for a period of five (5) years from the initial exercise date. The exercise price of the Common Warrants is $1.65 per share.

 

The Offering is expected to close on August 28, 2026. The net proceeds from the Offering are expected to be approximately $2,984,808, after deducting placement agent fees and other estimated offering expenses. The Company intends to use the net proceeds from the Offering for corporate development and general purposes and working capital.

 

In connection with the Offering, the Company entered into a placement agency agreement (the “Placement Agency Agreement”) with A.G.P./Alliance Global Partners (the “Placement Agent”), pursuant to which the Placement Agent agreed to serve as the Company’s sole placement agent in connection with the Offering. As compensation for the services provided by the Placement Agent in connection with the Offering, the Company agreed to pay the Placement Agent a cash fee of 6.50% of the gross proceeds which will be received by the Company from the sale of the securities at the closing. The Company also agreed to reimburse the Placement Agent for certain of its out-of-pocket accountable expenses incurred in connection with its services as placement agent in an amount not to exceed $50,000 in the aggregate.

 

The Securities were offered by the Company pursuant to the Company’s shelf registration statement on Form S-3 (File No. 333-273347) declared effective by the Securities and Exchange Commission (the “SEC”) on September 21, 2023 and the related prospectus supplement and accompanying prospectus.

 

Pursuant to the Purchase Agreement, the Company agreed that: (A) for a period of 45 days after the closing date of the Offering, the Company will not (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents (as defined in the Purchase Agreement) or (ii) file any registration statement or any amendment or supplement thereto, in each case subject to certain limited exceptions; and (B) from the date of the Purchase Agreement and until six (6) month following the closing date of the Offering, the Company will be prohibited from effecting or entering into an agreement to effect any issuance by the Company or any of its subsidiaries of Common Shares or Common Share Equivalents (as defined in the Purchase Agreement) (or a combination of units thereof) involving a Variable Rate Transaction (as defined in the Purchase Agreement), provided however, that the Company may enter into and/or issue Common Shares in an “at the market offering” with A.G.P./Alliance Global Partners after 30 days following the closing date of the Offering.

 

1

 

 

The Purchase Agreement contains customary representations and warranties, agreements and obligations, conditions to closing and termination provisions. In connection with the Offering, the Company’s directors and executive officers also entered into lock-up agreements with the Company, pursuant to which such directors and officers will not be permitted to, for a period of 45 days after the closing to offer, sell, contract to sell, hypothecate, pledge or otherwise dispose of (or enter into any transaction which is designed to, or might reasonably be expected to, result in the disposition at any time, including in the future (whether by actual disposition or effective economic disposition due to cash settlement or otherwise) by such directors and officers or their affiliates), their Company securities, subject to certain limited exceptions.

 

The foregoing descriptions of the Common Warrants, Pre-Funded Warrants, Purchase Agreement and Placement Agency Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of the Form of Common Warrant, Form of Pre-Funded Warrants, Form of Securities Purchase Agreement and Placement Agency Agreement, which are attached as Exhibits 4.1, 4.2, 10.1 and 10.2, respectively, hereto and incorporated by reference herein.

 

The legal opinion of Sullivan & Worcester LLP relating to the legality of the issuance and sale of the securities in the Registered Direct Offering is filed as Exhibit 5.1 to this Current Report on Form 8-K.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

Pursuant to the Concurrent Private Placement described in Item 1.01 above, which description is incorporated into this Item 3.02 by reference, the Common Warrants (including the Common Stock issuable upon exercise of the Common Warrants) (collectively, the “Private Securities”) were issued in reliance upon the exemption from registration pursuant to Section 4(a)(2) under the Securities Act and Regulation D under the Securities Act, and corresponding provisions of state securities or “blue sky” laws. The sale of the Private Securities did not involve a public offering and was made without general solicitation or general advertising. Accordingly, the Private Securities have not been registered under the Securities Act or any state securities laws and such securities may not be offered or sold in the United States absent registration, or an exemption from registration, under the Securities Act and any applicable state securities laws.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
4.1   Form of Common Warrant
4.2   Form of Pre-Funded Warrant
5.1   Legal opinion of Sullivan & Worcester LLP
10.1   Form of Securities Purchase Agreement
10.2   Placement Agency Agreement
23.1   Consent of Sullivan & Worcester LLP (included in Exhibit 5.1)
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PLURI INC.
   
Date: August 28, 2026 By: /s/ Liat Zalts
  Name:  Liat Zalts
  Title: Chief Financial Officer

 

 

3

 

 

Filing Exhibits & Attachments

8 documents